<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>PILMAN &#187; there</title>
	<atom:link href="http://www.tapanray.in/tag/there/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.tapanray.in</link>
	<description>A Tapan Ray Website</description>
	<lastBuildDate>Sun, 22 Mar 2026 10:59:18 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.4.2</generator>
		<item>
		<title>Seeing ghosts where there aren&#8217;t any</title>
		<link>http://www.tapanray.in/seeing-ghosts-where-there-arent-any/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=seeing-ghosts-where-there-arent-any</link>
		<comments>http://www.tapanray.in/seeing-ghosts-where-there-arent-any/#comments</comments>
		<pubDate>Mon, 10 Oct 2011 00:00:15 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[andrew]]></category>
		<category><![CDATA[any]]></category>
		<category><![CDATA[aren't]]></category>
		<category><![CDATA[attractive]]></category>
		<category><![CDATA[chris]]></category>
		<category><![CDATA[ghosts]]></category>
		<category><![CDATA[GSK]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[innovation]]></category>
		<category><![CDATA[investments]]></category>
		<category><![CDATA[pharmaceutical]]></category>
		<category><![CDATA[productivity]]></category>
		<category><![CDATA[R&D]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[Sanofi]]></category>
		<category><![CDATA[Seeing]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[there]]></category>
		<category><![CDATA[viebachar]]></category>
		<category><![CDATA[where]]></category>
		<category><![CDATA[witty]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=190</guid>
		<description><![CDATA[Seeing ghosts almost everywhere in the Indian pharmaceutical industry, especially where there aren&#8217;t any, has indeed become quite common nowadays, across the spectrum of stakeholders. The ‘ghosts’ could well reside in ‘100% Foreign Direct Investments (FDI) through automatic route in &#8230; <a href="http://www.tapanray.in/seeing-ghosts-where-there-arent-any/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/seeing-ghosts-where-there-arent-any/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>From Cross-Licensing to ‘Patent Pools’ and&#8230; India: Will there be a ground swell?</title>
		<link>http://www.tapanray.in/from-cross-licensing-to-patent-pools-and-india-will-there-be-a-ground-swell/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=from-cross-licensing-to-patent-pools-and-india-will-there-be-a-ground-swell</link>
		<comments>http://www.tapanray.in/from-cross-licensing-to-patent-pools-and-india-will-there-be-a-ground-swell/#comments</comments>
		<pubDate>Mon, 23 May 2011 00:00:49 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[a]]></category>
		<category><![CDATA[and]]></category>
		<category><![CDATA[andrew]]></category>
		<category><![CDATA[be]]></category>
		<category><![CDATA[Cross]]></category>
		<category><![CDATA[ground]]></category>
		<category><![CDATA[GSK]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[Licensing]]></category>
		<category><![CDATA[Open]]></category>
		<category><![CDATA[OSDD]]></category>
		<category><![CDATA[Patent]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[Pools]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[source]]></category>
		<category><![CDATA[swell]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[there]]></category>
		<category><![CDATA[to]]></category>
		<category><![CDATA[Will]]></category>
		<category><![CDATA[witty]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=254</guid>
		<description><![CDATA[Since many years, the global pharmaceutical industry has been making effective commercial use of cross-licensing, however, by and large, the industry still does not seem to be quite in favor of  &#8216;Patent Pools&#8217; for various reasons. The ‘Patent Pool’, as &#8230; <a href="http://www.tapanray.in/from-cross-licensing-to-patent-pools-and-india-will-there-be-a-ground-swell/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/from-cross-licensing-to-patent-pools-and-india-will-there-be-a-ground-swell/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Challenges for the Pharmaceutical Industry in the new paradigm – there are more questions than answers</title>
		<link>http://www.tapanray.in/challenges-for-the-pharmaceutical-industry-in-the-new-paradigm-there-are-more-questions-than-answers/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=challenges-for-the-pharmaceutical-industry-in-the-new-paradigm-there-are-more-questions-than-answers</link>
		<comments>http://www.tapanray.in/challenges-for-the-pharmaceutical-industry-in-the-new-paradigm-there-are-more-questions-than-answers/#comments</comments>
		<pubDate>Mon, 19 Apr 2010 01:00:54 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[2005]]></category>
		<category><![CDATA[Act]]></category>
		<category><![CDATA[answers]]></category>
		<category><![CDATA[are]]></category>
		<category><![CDATA[Challenges]]></category>
		<category><![CDATA[for]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[in]]></category>
		<category><![CDATA[industry]]></category>
		<category><![CDATA[IP]]></category>
		<category><![CDATA[IPR]]></category>
		<category><![CDATA[more]]></category>
		<category><![CDATA[New]]></category>
		<category><![CDATA[paradigm]]></category>
		<category><![CDATA[Patents]]></category>
		<category><![CDATA[pharmaceutical]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[questions]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[than]]></category>
		<category><![CDATA[the]]></category>
		<category><![CDATA[there]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=439</guid>
		<description><![CDATA[To get insight into the future challenges of the pharmaceutical industry in general ‘Complete Medical Group’of U.K recently conducted a study with a sizeable number of senior participants from the pharmaceutical companies of various sizes and involving many countries. The &#8230; <a href="http://www.tapanray.in/challenges-for-the-pharmaceutical-industry-in-the-new-paradigm-there-are-more-questions-than-answers/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/challenges-for-the-pharmaceutical-industry-in-the-new-paradigm-there-are-more-questions-than-answers/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>The ‘Climate Change’ and its impact on ‘Public health’: is there anything in it that we can do ourselves?</title>
		<link>http://www.tapanray.in/the-climate-change-and-its-impact-on-public-health-is-there-anything-in-it-that-we-can-do-ourselves/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=the-climate-change-and-its-impact-on-public-health-is-there-anything-in-it-that-we-can-do-ourselves</link>
		<comments>http://www.tapanray.in/the-climate-change-and-its-impact-on-public-health-is-there-anything-in-it-that-we-can-do-ourselves/#comments</comments>
		<pubDate>Mon, 01 Mar 2010 02:00:41 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[and]]></category>
		<category><![CDATA[anything]]></category>
		<category><![CDATA[can]]></category>
		<category><![CDATA[Change]]></category>
		<category><![CDATA[Climate]]></category>
		<category><![CDATA[do]]></category>
		<category><![CDATA[Health]]></category>
		<category><![CDATA[IMPACT]]></category>
		<category><![CDATA[in]]></category>
		<category><![CDATA[it]]></category>
		<category><![CDATA[its]]></category>
		<category><![CDATA[on]]></category>
		<category><![CDATA[ourselves]]></category>
		<category><![CDATA[public]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[that]]></category>
		<category><![CDATA[there]]></category>
		<category><![CDATA[we]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=461</guid>
		<description><![CDATA[The Lancet in its December 5, 12 and 19, 2009 issues published the following interesting studies:A. Public health benefits of strategies to reduce greenhouse-gas emissions: household energy B. Public health benefits of strategies to reduce greenhouse-gas emissions: urban land transport &#8230; <a href="http://www.tapanray.in/the-climate-change-and-its-impact-on-public-health-is-there-anything-in-it-that-we-can-do-ourselves/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/the-climate-change-and-its-impact-on-public-health-is-there-anything-in-it-that-we-can-do-ourselves/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Fixed Dose Combination’ drugs market in India is growing faster &#8211; are there enough regulatory checks and balances to prevent market entry of ‘irrational combinations’ to ensure patients’ safety?</title>
		<link>http://www.tapanray.in/fixed-dose-combination-drugs-market-in-india-is-growing-faster-are-there-enough-regulatory-checks-and-balances-to-prevent-market-entry-of-irrational-combinations-to-ensure/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=fixed-dose-combination-drugs-market-in-india-is-growing-faster-are-there-enough-regulatory-checks-and-balances-to-prevent-market-entry-of-irrational-combinations-to-ensure</link>
		<comments>http://www.tapanray.in/fixed-dose-combination-drugs-market-in-india-is-growing-faster-are-there-enough-regulatory-checks-and-balances-to-prevent-market-entry-of-irrational-combinations-to-ensure/#comments</comments>
		<pubDate>Sun, 26 Apr 2009 18:00:41 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[and]]></category>
		<category><![CDATA[are]]></category>
		<category><![CDATA[balances]]></category>
		<category><![CDATA[checks]]></category>
		<category><![CDATA[Combination]]></category>
		<category><![CDATA[combinations]]></category>
		<category><![CDATA[DCGI]]></category>
		<category><![CDATA[Dose]]></category>
		<category><![CDATA[drugs]]></category>
		<category><![CDATA[enough]]></category>
		<category><![CDATA[ensure]]></category>
		<category><![CDATA[entry]]></category>
		<category><![CDATA[faster]]></category>
		<category><![CDATA[FDC]]></category>
		<category><![CDATA[Fixed]]></category>
		<category><![CDATA[Growing]]></category>
		<category><![CDATA[in]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[irrational]]></category>
		<category><![CDATA[is]]></category>
		<category><![CDATA[market]]></category>
		<category><![CDATA[of]]></category>
		<category><![CDATA[Patients]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[prevent]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[Regulatory]]></category>
		<category><![CDATA[Safety]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[there]]></category>
		<category><![CDATA[to]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=909</guid>
		<description><![CDATA[The WHO Model of FDCs:The 2005 ʹProcedure to update and disseminate the WHO Model List of Essential Medicines, Criteria for Selection&#8216; includes the following statement regarding fixed dose combination products (FDCs):ʺMost essential medicines should be formulated as single compounds. Fixed‐dose &#8230; <a href="http://www.tapanray.in/fixed-dose-combination-drugs-market-in-india-is-growing-faster-are-there-enough-regulatory-checks-and-balances-to-prevent-market-entry-of-irrational-combinations-to-ensure/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/fixed-dose-combination-drugs-market-in-india-is-growing-faster-are-there-enough-regulatory-checks-and-balances-to-prevent-market-entry-of-irrational-combinations-to-ensure/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
